Diagnostic stewardship for sepsis: the need for risk stratification to triage patients for fast microbiology workflows

Papers of special note have been highlighted as: • of interest; •• of considerable interest

References

• 1 Rhodes A, Evans LE, Alhazzani W et al. Surviving sepsis campaign: international guidelines for management of sepsis and septic shock: 2016. Intensive Care Med. 43(3), 304–377 (2017).
  MedlineGoogle Scholar
• 2 Carrara E, Pfeffer I, Zusman O, Leibovici L, Paul M. Determinants of inappropriate empirical antibiotic treatment: systematic review and meta-analysis. Int. J. Antimicrob. Agents 51(4), 548–553 (2018). • An extensive evaluation of the impact of infections by multidrug-resistant organisms on patient's management and outcomes.
  Medline CASGoogle Scholar
• 3 Buehler SS, Madison B, Snyder SR et al. Effectiveness of practices to increase timeliness of providing targeted therapy for inpatients with bloodstream infections: a laboratory medicine best practices systematic review and meta-analysis. Clin. Microbiol. Rev. 29(1), 59–103 (2016). •• A comprehensive assessment of different fast microbiology workflows on pathogen identification and initiation of targeted therapy in bloodstream infections.
  MedlineGoogle Scholar
• 4 Tabah A, Koulenti D, Laupland K et al. Characteristics and determinants of outcome of hospital-acquired bloodstream infections in intensive care units: the EUROBACT international cohort study. Intensive Care Med. 38(12), 1930–1945 (2012).
  MedlineGoogle Scholar
• 5 Dubourg G, Lamy B, Ruimy R. Rapid phenotypic methods to improve the diagnosis of bacterial bloodstream infections: meeting the challenge to reduce the time to result. Clin. Microbiol. Infect. 24(9), 935–943 (2018).
  Medline CASGoogle Scholar
• 6 Peker N, Couto N, Sinha B, Rossen JW. Diagnosis of bloodstream infections from positive blood cultures and directly from blood samples: recent developments in molecular approaches. Clin. Microbiol. Infect. 24(9), 944–955 (2018). •• An exhaustive update on recent developments of molecular methods in the diagnosis of bloodstream infections.
  Medline CASGoogle Scholar
• 7 Arena F, Giani T, Pollini S, Viaggi B, Pecile P, Rossolini GM. Molecular antibiogram in diagnostic clinical microbiology: advantages and challenges. Future Microbiol. 12, 361–364 (2017).
  CASGoogle Scholar
• 8 Bookstaver PB, Nimmich EB, Smith TJ et al. Cumulative effect of an antimicrobial stewardship and rapid diagnostic testing bundle on early streamlining of antimicrobial therapy in gram-negative bloodstream infections. Antimicrob. Agents Chemother. 61(9), e00189–17 (2017).
  Medline CASGoogle Scholar
• 9 Barlam TF, Cosgrove SE, Abbo LM et al. Implementing an antibiotic stewardship program: guidelines by the Infectious Diseases Society of America and the Society for Healthcare Epidemiology of America. Clin. Infect. Dis. 62(10), e51–e77 (2016).
  MedlineGoogle Scholar
• 10 Menichetti F, Falcone M, Lopalco P et al. The GISA call to action for the appropriate use of antimicrobials and the control of antimicrobial resistance in Italy. Int. J. Antimicrob. Agents. 52(2), 127–134 (2018).
  Medline CASGoogle Scholar
• 11 US Food and Drug Association. Companion Diagnostics (2018). www.fda.gov/MedicalDevices/ProductsandMedicalProcedures/InVitroDiagnostics/ucm407297.htm.
  Google Scholar
• 12 Messacar K, Parker SK, Todd JK, Dominguez SR. Implementation of rapid molecular infectious disease diagnostics: the role of diagnostic and antimicrobial stewardship. J. Clin. Microbiol. 55(3), 715–723 (2017). •• An overview of features and aims of diagnostic stewardship and its connection to antimicrobial stewardship.
  MedlineGoogle Scholar
• 13 Vincent JL, De Mendonça A, Cantraine F et al. Use of the SOFA score to assess the incidence of organ dysfunction/failure in intensive care units: results of a multicenter, prospective study. Crit. Care Med. 26(11), 1793–1800 (1998).
  Medline CASGoogle Scholar
• 14 Quan H, Li B, Couris CM et al. Updating and validating the Charlson comorbidity index and score for risk adjustment in hospital discharge abstracts using data from 6 countries. Am. J. Epidemiol. 173(6), 676–682 (2011).
  MedlineGoogle Scholar
• 15 Singer M, Deutschman CS, Seymour CW et al. The third international consensus definitions for sepsis and septic shock (Sepsis-3). JAMA 315(8), 801–810 (2016).
  Medline CASGoogle Scholar
• 16 Russo A, Falcone M, Gutiérrez-Gutiérrez B et al. Predictors of outcome in patients with severe sepsis or septic shock due to extended-spectrum β-lactamase-producing Enterobacteriaceae. Int. J. Antimicrob. Agents 52(5), 577–585 (2018).
  Medline CASGoogle Scholar
• 17 Rhee JY, Kwon KT, Ki HK et al. Scoring systems for prediction of mortality in patients with intensive care unit-acquired sepsis: a comparison of the PITT bacteremia score and the Acute Physiology and Chronic Health Evaluation II scoring systems. Shock 31(2), 146–150 (2009).
  MedlineGoogle Scholar
• 18 Chen C, Yan M, Hu C, Lv X, Zhang H, Chen S. Diagnostic efficacy of serum procalcitonin, C-reactive protein concentration and clinical pulmonary infection score in ventilator-associated pneumonia. Med. Sci. 34, 26–32 (2018).
  Google Scholar
• 19 Scudeller L, Bassetti M, Concia E et al. Medical wards invasive candidiasis algorithms (MEDICAL): consensus proposal for management. Eur. J. Intern. Med. 34, 45–53 (2016).
  MedlineGoogle Scholar
• 20 Dickstein Y, Edelman R, Dror T, Hussein K, Bar-Lavie Y, Paul M. Carbapenem-resistant Enterobacteriaceae colonization and infection in critically ill patients: a retrospective matched cohort comparison with non-carriers. J. Hosp. Infect. 94(1), 54–59 (2016). • Clinical study assessing the association of carbapenem-resistant Enterobacterales colonization with the risk of infection by the colonizing strain.
  Medline CASGoogle Scholar
• 21 Wirz Y, Meier MA, Bouadma L et al. Effect of procalcitonin-guided antibiotic treatment on clinical outcomes in intensive care unit patients with infection and sepsis patients: a patient-level meta-analysis of randomized trials. Crit. Care 22(1), 191 (2018).
  MedlineGoogle Scholar
• 22 Bartoletti M, Antonelli M, Blasi FAB et al. Procalcitonin-guided antibiotic therapy: an expert consensus. Clin. Chem. Lab. Med. 56(8), 1223–1229 (2018).
  Medline CASGoogle Scholar
• 23 Viaggi B, Poole D, Tujjar O, Marchiani S, Ognibene A, Finazzi S. Mid regional pro-adrenomedullin for the prediction of organ failure in infection. Results from a single centre study. PLoS ONE 13(8), e0201491 (2018). • Clinical study on the ability of the novel biomarker mid-regional proadrenomedullin in predicting the evolution to sepsis of infected patients in intensive care unit.
  MedlineGoogle Scholar
• 24 Roberts JA, Abdul-Aziz MH, Lipman J et al. Individualised antibiotic dosing for patients who are critically ill: challenges and potential solutions. Lancet Infect. Dis. 14(6), 498–509 (2014).
  MedlineGoogle Scholar